Cite
HARVARD Citation
Traussnigg, S. et al. (2019). Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial. Lancet gastroenterology and hepatology. pp. 781-793. [Online].